Drug and health care stocks: The right prescription for 2009 - Steven Halpern

Sign Up | Log In | What is SocialPicks?

Drug and health care stocks: The right prescription for 2009
Jan 05, 2009 08:30 PM UTC

Steven Halpern

Return	Risk
+4.82%	MID

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
BMY		01/05/09	+0.60%	01/05/09
PFE		01/05/09	-29.20%	03/10/09
JNJ	n/a
MYGN		01/05/09	-36.56%	--
HMSY		01/05/09	-6.93%	01/11/09
EBS		01/05/09	-11.04%	01/10/09
BIIB		01/05/09	-4.28%	--
CSKI		01/05/09	-27.91%	--
AMED		01/05/09	+14.58%	01/13/09
ZMH		01/05/09	+2.42%	01/09/09

Via BloggingStocks:

Filed under: Pfizer (PFE), Newsletters, Johnson and Johnson (JNJ), Bristol-Myers Squibb (BMY), Stocks to Buy, Best Stocks for 2009

Health care has long been considered a recession-resistant business. Given the current economic challenges, it's little surprise that in our survey of favorite stocks for the coming year, a number of leading advisors turned to this classic defensive sector.

In this year's Top Stock Picks from 75 advisors report, we found an intriguing group of medical-related stocks, from speculation in emerging biotech to well-established pharmaceutical firms, and from medical products makers to medical services firms focused on increasing health care efficiency and early disease detection.

Mike Cintolo, editor of The Cabot Market Letter, thinks Myriad Genetics (NASDAQ: MYGN) could be a "big winner in 2009," The company is a lead in the new field of cancer predisposition testing. For Mike's full report, read Top Stock Picks '09: Myriad Genetics.

Chuck Carlson, editor of The DRIP Investor, sees both quality and potential in Bristol-Myers Squibb (NYSE: BMY). For Chuck's full report, read Top Stock Picks '09: Bristol-Myers Squibb.

Continue reading Drug and health care stocks: The right prescription for 2009

Drug and health care stocks: The right prescription for 2009 originally appeared on BloggingStocks on Mon, 05 Jan 2009 15:30:00 EST. Please see our terms for use of feeds.

PermalinkÂ |Â Email thisÂ |Â Comments

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.